This reaction converts the reduced form of glutathione (GSH) into oxidized glutathione (GSSG), which is then reduced back to GSH by glutathione reductase (GR), using electrons from NADPH (Dringen and Arend, 2025)
Innovative trial designs To overcome the limitations of traditional therapeutic development in the context of drug resistance, innovative clinical trial designs are being increasingly adopted (Fig
A researcher leaves a vial on the lab bench, thinking its stable, only to find their next experiment yields bizarre, unreliable data
With Durham Peptides' two formats: 500mg at C$114.99 = C$0.230 per mg 1000mg at C$165.00 = C$0.165 per mg (~28% cheaper per mg) The 1000mg vial is meaningfully cheaper per milligram
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al